204 related articles for article (PubMed ID: 22653282)
1. Assessment of pulmonary melanoma metastases with 18F-FDG PET/CT: which PET-negative patients require additional tests for definitive staging?
Mayerhoefer ME; Prosch H; Herold CJ; Weber M; Karanikas G
Eur Radiol; 2012 Nov; 22(11):2451-7. PubMed ID: 22653282
[TBL] [Abstract][Full Text] [Related]
2. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?
Casneuf V; Delrue L; Kelles A; Van Damme N; Van Huysse J; Berrevoet F; De Vos M; Duyck P; Peeters M
Acta Gastroenterol Belg; 2007; 70(4):331-8. PubMed ID: 18330088
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic performance of whole body dual modality 18F-FDG PET/CT imaging for N- and M-staging of malignant melanoma: experience with 250 consecutive patients.
Reinhardt MJ; Joe AY; Jaeger U; Huber A; Matthies A; Bucerius J; Roedel R; Strunk H; Bieber T; Biersack HJ; Tüting T
J Clin Oncol; 2006 Mar; 24(7):1178-87. PubMed ID: 16505438
[TBL] [Abstract][Full Text] [Related]
4. Direct comparison of [18F]FDG PET/CT with PET alone and with side-by-side PET and CT in patients with malignant melanoma.
Mottaghy FM; Sunderkötter C; Schubert R; Wohlfart P; Blumstein NM; Neumaier B; Glatting G; Ozdemir C; Buck AK; Scharffetter-Kochanek K; Reske SN
Eur J Nucl Med Mol Imaging; 2007 Sep; 34(9):1355-64. PubMed ID: 17295038
[TBL] [Abstract][Full Text] [Related]
5. "One-stop-shop" staging: should we prefer FDG-PET/CT or MRI for the detection of bone metastases?
Heusner T; Gölitz P; Hamami M; Eberhardt W; Esser S; Forsting M; Bockisch A; Antoch G
Eur J Radiol; 2011 Jun; 78(3):430-5. PubMed ID: 19945240
[TBL] [Abstract][Full Text] [Related]
6. Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography and computed tomography in patients with melanoma with palpable lymph node metastases: diagnostic accuracy and impact on treatment.
Bastiaannet E; Wobbes T; Hoekstra OS; van der Jagt EJ; Brouwers AH; Koelemij R; de Klerk JM; Oyen WJ; Meijer S; Hoekstra HJ
J Clin Oncol; 2009 Oct; 27(28):4774-80. PubMed ID: 19720925
[TBL] [Abstract][Full Text] [Related]
7. Clinical value of including the head and lower extremities in 18F-FDG PET/CT imaging for patients with malignant melanoma.
Niederkohr RD; Rosenberg J; Shabo G; Quon A
Nucl Med Commun; 2007 Sep; 28(9):688-95. PubMed ID: 17667747
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of small pulmonary nodules with little or no 18F-FDG uptake on PET/CT images of patients with nonthoracic malignancies.
O JH; Yoo IeR; Kim SH; Sohn HS; Chung SK
J Nucl Med; 2007 Jan; 48(1):15-21. PubMed ID: 17204694
[TBL] [Abstract][Full Text] [Related]
9. The sensitivity of 18F-fluorodeoxyglucose positron emission tomography in the evaluation of metastatic pulmonary nodules.
Fortes DL; Allen MS; Lowe VJ; Shen KR; Wigle DA; Cassivi SD; Nichols FC; Deschamps C
Eur J Cardiothorac Surg; 2008 Dec; 34(6):1223-7. PubMed ID: 18848459
[TBL] [Abstract][Full Text] [Related]
10. (123)I-BZA2 as a melanin-targeted radiotracer for the identification of melanoma metastases: results and perspectives of a multicenter phase III clinical trial.
Cachin F; Miot-Noirault E; Gillet B; Isnardi V; Labeille B; Payoux P; Meyer N; Cammilleri S; Gaudy C; Razzouk-Cadet M; Lacour JP; Granel-Brocard F; Tychyj C; Benbouzid F; Grange JD; Baulieu F; Kelly A; Merlin C; Mestas D; Gachon F; Chezal JM; Degoul F; D'Incan M
J Nucl Med; 2014 Jan; 55(1):15-22. PubMed ID: 24263087
[TBL] [Abstract][Full Text] [Related]
11. 18F-FDG PET and PET/CT for detection of pulmonary metastases from musculoskeletal sarcomas.
Iagaru A; Chawla S; Menendez L; Conti PS
Nucl Med Commun; 2006 Oct; 27(10):795-802. PubMed ID: 16969262
[TBL] [Abstract][Full Text] [Related]
12. High-risk melanoma: accuracy of FDG PET/CT with added CT morphologic information for detection of metastases.
Strobel K; Dummer R; Husarik DB; Pérez Lago M; Hany TF; Steinert HC
Radiology; 2007 Aug; 244(2):566-74. PubMed ID: 17641374
[TBL] [Abstract][Full Text] [Related]
13. PET/CT in malignant melanoma: contrast-enhanced CT versus plain low-dose CT.
Pfluger T; Melzer HI; Schneider V; La Fougere C; Coppenrath E; Berking C; Bartenstein P; Weiss M
Eur J Nucl Med Mol Imaging; 2011 May; 38(5):822-31. PubMed ID: 21210112
[TBL] [Abstract][Full Text] [Related]
14. Role of FDG-PET in the assessment of survival prognosis in melanoma.
Pleiss C; Risse JH; Biersack HJ; Bender H
Cancer Biother Radiopharm; 2007 Dec; 22(6):740-7. PubMed ID: 18158764
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic accuracy of contrast-enhanced FDG-PET/CT in primary staging of cutaneous malignant melanoma.
Veit-Haibach P; Vogt FM; Jablonka R; Kuehl H; Bockisch A; Beyer T; Dahmen G; Rosenbaum S; Antoch G
Eur J Nucl Med Mol Imaging; 2009 Jun; 36(6):910-8. PubMed ID: 19156409
[TBL] [Abstract][Full Text] [Related]
16. CT imaging of bone and bone marrow infiltration in malignant melanoma--Challenges and limitations for clinical staging in comparison to 18FDG-PET/CT.
Bier G; Hoffmann V; Kloth C; Othman AE; Eigentler T; Garbe C; La Fougère C; Pfannenberg C; Nikolaou K; Klumpp B
Eur J Radiol; 2016 Apr; 85(4):732-8. PubMed ID: 26971416
[TBL] [Abstract][Full Text] [Related]
17. Integrated fluorine-18 fluorodeoxyglucose (18F-FDG) PET/CT compared to standard contrast-enhanced CT for characterization and staging of pulmonary tumors eligible for surgical resection.
Quaia E; Tona G; Gelain F; Lubin E; Pizzolato R; Boscolo E; Bussoli L
Acta Radiol; 2008 Nov; 49(9):995-1004. PubMed ID: 18651256
[TBL] [Abstract][Full Text] [Related]
18. 11C-acetate and 18F-FDG PET/CT for clinical staging and selection of patients with hepatocellular carcinoma for liver transplantation on the basis of Milan criteria: surgeon's perspective.
Cheung TT; Ho CL; Lo CM; Chen S; Chan SC; Chok KS; Fung JY; Yan Chan AC; Sharr W; Yau T; Poon RT; Fan ST
J Nucl Med; 2013 Feb; 54(2):192-200. PubMed ID: 23321459
[TBL] [Abstract][Full Text] [Related]
19. PET/MR imaging in the detection and characterization of pulmonary lesions: technical and diagnostic evaluation in comparison to PET/CT.
Rauscher I; Eiber M; Fürst S; Souvatzoglou M; Nekolla SG; Ziegler SI; Rummeny EJ; Schwaiger M; Beer AJ
J Nucl Med; 2014 May; 55(5):724-9. PubMed ID: 24652827
[TBL] [Abstract][Full Text] [Related]
20. Indeterminate lung nodules in cancer patients: pretest probability of malignancy and the role of 18F-FDG PET/CT.
Evangelista L; Panunzio A; Polverosi R; Pomerri F; Rubello D
AJR Am J Roentgenol; 2014 Mar; 202(3):507-14. PubMed ID: 24555586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
